www.varchev.com

US trading session with positive close

Rating:

12345
Loading...

American stocks closed higher today, supported by the better than expected corporate financial results. NASDAQ and S&P 500 added to already record highs. Investors are broadly optimistic about the corporate results for the quarter. The markets continue to march up despite of the situation in Washington and the delay of the health care reforms. In the absence of any negative news and no geo-political risks also support the indices. The US data for the housing starts and building permits added to the positive optimism. So far  out of the 53 corporations that reported results in the S&P index, 77% of them had better than expected results. Some of the analysts think that there is divergence between the bond market and the stock market, as the bond prices are signaling a possibility of slowing economy but the stock market continue to climb up. The VIX index fell below 10.

DJIA:  66.02 points/ 0.31%  - 21,640.75

S&P:  13.22 points/   0.54%   - 2,473.83

NASDAQ:  40.74 points/ 0.64%  -  6,385.04

RUSS 2000:  13.31 points/ 0.93% - 1,440.92

VIX:  9.75

In the S&P almost all sectors were up, with Energy and Tech with most gains.

For the Dоw Jones also finished higher but it was held back because of IBM traded lower, which caused 45 points lower close. Boeing however was higher.

The tech and banking sectors were the most gainers from today's session.

The price of Oil continued to trade higher, reaching around $47.10 per barrel. The USD was slightly higher, but it still at the lowest levels for a while. The Euro dipped slightly, but this is just a correction. The euro is giving us a clear signal for long, but we will wait for the ECB rate decision meeting tomorrow and then look for a good levels to enter long.

Source of the graph: Bloomberg Pro Terminal

Trader - S. Fuchedzhiev


 Varchev Traders

Read more:

RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy